Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with ...

WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

Like Viagra, Stendra and Levitra, Cialis is highly effective as a treatment for ED. But no medication has a 100 percent success rate, and Cialis is … ...

Millions of people at risk of HIV in low- and middle-income countries (LMICs) will soon have access to a powerful new prevention option, a low-cost, generic version of lenacapavir, the world’s first ...

A posting on Reddit has suggested what urologists already suspect… many gay men are experimenting with, or regularly taking, medications to make their equipment harder. This is despite the fact that ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The SEC stated that it has approved the generic listing standards proposed by top US exchanges for commodity-based ETFs. Exchanges may list and trade commodity-based trust shares that meet listing ...

AbbVie (ABBV) announced that it has settled litigation with all generic manufacturers that filed abbreviated new drug applications with the Food and Drug Administration for generic versions of ...

Aug 28 (Reuters) - The U.S. Food and Drug Administration has approved Teva Pharmaceuticals' (TEVA.TA), opens new tab cheaper generic version of Novo Nordisk's (NOVOb.CO), opens new tab older ...

Erectile dysfunction (ED) is more than just a medical condition—it’s a challenge that impacts millions of men’s confidence, relationships, and overall quality of life. Once a topic shrouded in ...

July 16 (Reuters) - A U.S. federal judge rejected Swiss drugmaker Novartis' (NOVN.S), opens new tab request for a preliminary injunction to stop MSN Pharmaceuticals from selling a generic version of ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper generic copycats You can save this article by registering for free here. Or ...